CN1085097C - Medicine for treating prostatic hyperplasia - Google Patents
Medicine for treating prostatic hyperplasia Download PDFInfo
- Publication number
- CN1085097C CN1085097C CN99123036A CN99123036A CN1085097C CN 1085097 C CN1085097 C CN 1085097C CN 99123036 A CN99123036 A CN 99123036A CN 99123036 A CN99123036 A CN 99123036A CN 1085097 C CN1085097 C CN 1085097C
- Authority
- CN
- China
- Prior art keywords
- medicine
- treatment
- prostatic hyperplasia
- radix
- pulverizing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese medicine preparation for treating prostatic hyperplasia and prostatitis, which is prepared from Chinese crude drugs, such as astragalus root, Chinese angelica root, chicken's gizzard-skin, etc. through preparation technology of washing, drying, pulverizing, granulating, packing, etc. The present invention has the advantages of short course of treatment, quickly taking effect and high curative rate.
Description
The present invention relates to the field of Chinese medicines, especially a kind of prostatic hyperplasia, prostatitic Chinese medicine preparation of being used for the treatment of.
Prostatic hyperplasia (hypertrophy), prostatitis are common person in middle and old age's andropathys, and cardinal symptom is: urgent micturition, frequent micturition, dysurea.This disease can be brought inconvenience and misery to patient's life.Medicine commonly used at present has " bamboo grove peace ", " QIANLIEKANG ", " prostate disease ", " Prostat " and various Chinese medicine preparation etc.Bad during these curative effect of medication fashions, the course of treatment is often longer, and clinical cure rate is low, and the need that have are month after month taken throughout the year, and curative effect is also not remarkable.Current, this disease sickness rate obviously is the gesture of rising, and a patient hastens forward urgent need good effect, the medicine appearance that cure rate is high the age.
The object of the present invention is to provide a kind of treatment prostatic hyperplasia, prostatitic medicine, its short treating period, instant effect, cure rate height.
Technical scheme of the present invention is: it adopts pure Chinese medicinal preparation, medicine comprises: the Radix Astragali, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Endothelium Corneum Gigeriae Galli, the Rhizoma Atractylodis Macrocephalae, Radix Morindae Officinalis, Rhizoma Corydalis, Radix Notoginseng, Fructus Forsythiae, Hirudo, Olibanum, Herba Taxilli, Myrrha, the Radix Rehmanniae, Radix Aconiti Lateralis Preparata, Squama Manis, Radix Adenophorae (Radix Glehniae), Carapax Trionycis, Gekko Swinhonis, Concha Ostreae, Fructus Arctii, Fructus Aurantii, succinum, Cornu Cervi Degelatinatum, the content of various medicines is respectively: Radix Astragali 1-10% Endothelium Corneum Gigeriae Galli 1-10% Rhizoma Corydalis 1-10% water little molehill 1-10% Radix Angelicae Sinensis 1-10% Rhizoma Atractylodis Macrocephalae 1-10% Radix Notoginseng 1-10% Olibanum 1-10% Rhizoma Chuanxiong 1-5% Radix Morindae Officinalis 1-5% Fructus Forsythiae 1-5% Herba Taxilli 1-5% Myrrha 1-10% gun additioner 1-10% Radix Adenophorae (Radix Glehniae) 1-10% Concha Ostreae 1-10% Radix Rehmanniae 1-10% Squama Manis 1-10% Carapax Trionycis 1-10% Gekko Swinhonis 1-10% succinum 1-10% Fructus Arctii 1-10% Fructus Aurantii 1-10% Cornu Cervi Degelatinatum 1-10%
The present invention is the medicament of making by following preparation technology:
(1) cleans: need clean medical material and wash.
(2) oven dry: all medical materials are dried with equipment.
(3) pulverize: the pulverizing medicinal materials after will drying.
(4) granulate: the medical material of pulverizing is made dissolved granule.
(5) packing: with the medicine weighing and bagging that machines.
Embodiments of the invention:
Embodiment 1 each the explosive component content Radix Astragali 4.5% the membrane of a chicken's gizzard 4.5% corydalis tuber 4.5% water little molehill 4.5% Radix Angelicae Sinensis 4.5% bighead atractylodes rhizome 4.5% pseudo-ginseng 4.5% frankincense 4.5% Ligusticum wallichii 2.5% Morinda officinalis 2.5% capsule of weeping forsythia 2.5% parasitic loranthus 2.5% myrrh 4.5% gun additioner 4.5% the root of straight ladybell 4.5% oyster 4.5% dried rhizome of rehmannia 4.5% pangolin 4.5% turtle shell 4.5% gecko 4.5% amber 4.5% great burdock achene 4.5% Fructus Aurantii 4.5% cornu cerve degelatinatum 4.5% present embodiment preparation technology:
(1) cleans: need clean medical material and wash.
(2) oven dry: all medical materials are dried with equipment.
(3) pulverize: the pulverizing medicinal materials after will drying.
(4) granulate: the medical material of pulverizing is made dissolved granule.
(5) packing:with the medicine weighing and bagging that machines. embodiment two: each the explosive component content Radix Astragali 4% the membrane of a chicken's gizzard 4% corydalis tuber 4% water little molehill 4% Radix Angelicae Sinensis 4% bighead atractylodes rhizome 4% pseudo-ginseng 4% frankincense 4% Ligusticum wallichii 2% Morinda officinalis 2% capsule of weeping forsythia 2% parasitic loranthus 2% myrrh 5% gun additioner 5% the root of straight ladybell 5% oyster 5% dried rhizome of rehmannia 5% pangolin 5% turtle shell 5% gecko 5% amber 5% great burdock achene 5% Fructus Aurantii 5% cornu cerve degelatinatum 5% present embodiment preparation technology is identical with embodiment one. Embodiment three: each the explosive component content Radix Astragali 4.8% the membrane of a chicken's gizzard 4.8% corydalis tuber 4.8% water little molehill 4.8% Radix Angelicae Sinensis 4.8% bighead atractylodes rhizome 4.8% pseudo-ginseng 4.8% frankincense 4.8% Ligusticum wallichii 1% Morinda officinalis 1% capsule of weeping forsythia 1% parasitic loranthus 1% myrrh 4.8% gun additioner 4.8% the root of straight ladybell 4.8% oyster 4.8% dried rhizome of rehmannia 4.8% pangolin 4.8% turtle shell 4.8% gecko 4.8% amber 4.8% great burdock achene 4.8% Fructus Aurantii 4.8% cornu cerve degelatinatum 4.8% present embodiment preparation technology is identical with embodiment one.
This medicine is a hereditary recipe, and the inventor is in clinical practice for many years, and with these powdered medicine treatment prostatic hyperplasia 342 examples, this powder is by name: infirmity must leading to.All case Jun Jing city hospital at county level ultrasound diagnosis are confirmed as prostatic hyperplasia in conjunction with clinical symptoms, and wherein the age reckling is 28 years old, the maximum 76 years old, 54 years old mean age, course of disease 1-3 person 156 examples, 4-10 person's 132 examples, person's 54 examples more than 10 years.
The course of treatment standard: (one) clinical recovery, sings and symptoms all disappears, and does not recur, ultrasound diagnosis, prostatic hyperplasia part almost disappears or recovers normal.
(2) take a turn for the better: symptom and sign disappears substantially, does not have recurrence, ultrasound diagnosis, and hypertrophy is partly dwindled more than 1/2 or 2/3.
After using the treatment of this medicine, stop using without exception other any medicine and therapy are thrown the treatment of " infirmity must leading to " powder, cured person the shortest course of treatment of treatment time, the longest six courses of treatment, average three courses of treatment, clinical cure rate reaches 82%, improvement rate 16%, total effective rate reaches 100%, hypertrophy part is dwindled significantly or recovers normally frequent micturition, urgent micturition, cardinal symptoms such as dysurea disappear thereupon.
Curative effect of the present invention is showed by model case.
Li Zengsheng: 68 years old, the Hongshan District people of Chifeng.1989 at Chifeng City hospital hospitalization prostatic hyperplasia, clinical symptoms: frequent micturition, and urgent micturition, dysurea, it is invalid to take other medicines, changes clothes powder of the present invention in June, 1998, heals entirely after two courses of treatment.
Zhang Yumin: 61 years old, the Songshan District people of Chifeng.Ultrasound diagnosis is diagnosed as prostatic hyperplasia, and it is invalid to take medicines such as " QIANLIEKANG ", uses powder of the present invention instead, recovery from illness two courses of treatment, and it is normal that the ultrasound diagnosis prostate recovers.
Open and send out: 28 years old, the Ning Dixian people of Chifeng.Suffer from prostatitis, take powder symptom one course of treatment of the present invention and subtract greatly, recovery from illness two courses of treatment is followed up a case by regular visits to after 1 year and is not had recurrence.
Guo Yaguang: 30 years old, people from Aohan Banner, Chifeng, gold mine workman.Nineteen ninety-five was once suffered from prostatitis, after take Chinese medicine and western medicine and cure, because underground work toils away, humidity, mining area hospital in 1996 ultrasound diagnosis is diagnosed as prostatic hyperplasia, it is invalid to take a large amount of Chinese medicines and " prostate disease " medicine of etc.ing, rises in August, 1997 and obeys one course of treatment of powder of the present invention, and symptom is clearly better, symptom complete obiteration two courses of treatment, ultrasound diagnosis recover normal.
Claims (2)
1. a Chinese medicine preparation for the treatment of hyperplasia of prostate is characterized in that it is the particle electuary of being made by the material medicine of following percentage by weight: Radix Astragali 1-10% the membrane of a chicken's gizzard 1-10% corydalis tuber 1-10% water little molehill 1-10% Radix Angelicae Sinensis 1-10% bighead atractylodes rhizome 1-10% pseudo-ginseng 1-10% frankincense 1-10% Ligusticum wallichii 1-5% Morinda officinalis 1-5% capsule of weeping forsythia 1-5% parasitic loranthus 1-5% myrrh 1-10% gun additioner 1-10% the root of straight ladybell 1-10% oyster 1-10% dried rhizome of rehmannia 1-10% pangolin 1-10% turtle shell 1-10% gecko 1-10% amber 1-10% great burdock achene 1-10% Fructus Aurantii 1-10% cornu cerve degelatinatum 1-10%.
2. Chinese medicine preparation according to claim 1 is characterized in that it is the medicament of making by following preparation technology:
(1) clean: need clean medical material and wash,
(2) oven dry: all medical materials are dried with equipment,
(3) pulverize: the pulverizing medicinal materials after will drying,
(4) granulate: the medical material of pulverizing is made dissolved granule,
(5) packing: with the medicine weighing and bagging that machines.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN99123036A CN1085097C (en) | 1999-10-26 | 1999-10-26 | Medicine for treating prostatic hyperplasia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN99123036A CN1085097C (en) | 1999-10-26 | 1999-10-26 | Medicine for treating prostatic hyperplasia |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1294013A CN1294013A (en) | 2001-05-09 |
CN1085097C true CN1085097C (en) | 2002-05-22 |
Family
ID=5282748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN99123036A Expired - Fee Related CN1085097C (en) | 1999-10-26 | 1999-10-26 | Medicine for treating prostatic hyperplasia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1085097C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI693938B (en) * | 2019-06-12 | 2020-05-21 | 康品科技有限公司 | Use of burdock extract |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6790464B2 (en) * | 2003-01-16 | 2004-09-14 | Healthaid Enterprise Pte. Ltd. | Herbal compositions for prostate conditions |
CN100342888C (en) * | 2005-03-14 | 2007-10-17 | 庹元斌 | Chinese medicine preparation for treating prostatic hyperplasia |
CN101579412B (en) * | 2008-05-15 | 2011-04-20 | 北京北大维信生物科技有限公司 | Medicinal composition for treating prostatauxe and preparation method thereof |
CN101461841B (en) * | 2009-01-09 | 2011-02-16 | 黄卫忠 | Chinese patent medicine for treating prostatoplasia |
CN101647946B (en) * | 2009-08-21 | 2011-10-26 | 李丹 | Hyperplasia-ablating pill for treating prostate hyperplasia |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1148964A (en) * | 1995-10-23 | 1997-05-07 | 张克忠 | Tongniaoling for diuresis |
CN1169308A (en) * | 1996-06-29 | 1998-01-07 | 郭万启 | Prepatatory Chinese medicine for treatment of prostate hyperplasia, prostatitis and urinary stone |
-
1999
- 1999-10-26 CN CN99123036A patent/CN1085097C/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1148964A (en) * | 1995-10-23 | 1997-05-07 | 张克忠 | Tongniaoling for diuresis |
CN1169308A (en) * | 1996-06-29 | 1998-01-07 | 郭万启 | Prepatatory Chinese medicine for treatment of prostate hyperplasia, prostatitis and urinary stone |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI693938B (en) * | 2019-06-12 | 2020-05-21 | 康品科技有限公司 | Use of burdock extract |
Also Published As
Publication number | Publication date |
---|---|
CN1294013A (en) | 2001-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1193775C (en) | Rheumatoid disease treating capsule | |
CN1085097C (en) | Medicine for treating prostatic hyperplasia | |
CN101099794A (en) | Medicine for treating rheumatic arthritis and rheumatoid arthritis | |
CN1103223C (en) | Chinese medicine for treating cholecystitis | |
CN1085099C (en) | Medicine for treating thyroid enlargement and thyroidism | |
CN108543044B (en) | Combined medicine for treating acne and application thereof | |
CN1476884A (en) | Inflammation-relieving plaster and its production method | |
CN104587267A (en) | Traditional Chinese medicine composition for treating psoriasis | |
CN103536815A (en) | Traditional Chinese medicinal composition for treating hemorrhoids symptoms | |
CN101543577A (en) | Traditional Chinese medicine composition for curing whelk and preparation method thereof | |
CN101152497A (en) | Traditional Chinese medicine for treating acne in young people | |
CN1814153B (en) | Medicine composition for preventing and treating breast cancer and preparing method | |
CN1965974A (en) | Medicament for treating psoriasis, preparation process and using method thereof | |
CN103690922A (en) | Traditional Chinese medicinal composition for treating polycystic ovarian syndrome and application thereof | |
CN1240415C (en) | Tablets against allergic purpura | |
CN102078571B (en) | Drug for treating early cirrhosis ascites | |
CN101254256A (en) | Clearing blood nourishing heart powder | |
CN105327121A (en) | Traditional Chinese medicine composition for treating female postmenopausal osteoporosis and preparing method thereof | |
CN1056530C (en) | Chinese medicinal herb composition for treating habitual oppilation | |
CN1085098C (en) | Medicine for treating mastoplasia | |
CN103721188B (en) | A kind of injection care drug preventing cerebrovascular sclerosis and preparation method thereof | |
CN101450133A (en) | Medicine for treating abdominopelvic cavity disease postoperative intestinal adhesion | |
CN101966329A (en) | Medicament for treating rash | |
CN103432358B (en) | Medicament for treating psoriasis | |
CN102018811A (en) | Chinese materia medica preparation for treating urticaria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
BB1A | Publication of application | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |